UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 14, 2009
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware
|
1-3619
|
13-5315170
|
(State or other Jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
10017
(Zip Code) |
Registrant's telephone number, including area code:
(212) 733-2323
Not Applicable
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On December 14, 2009, the Board of Directors of Pfizer Inc. (the "Company") approved certain amendments to the Company's By-laws, as follows:
The preceding is qualified in its entirety by reference to the Company’s amended and restated By-laws, which are attached hereto as Exhibit 3.1 and are incorporated herein by reference. |
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits |
||
Exhibit No. | Description | |
Exhibit 3.1 | Pfizer Inc. By-laws, as amended on December 14, 2009. |
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC.
|
||
By: /s/ Matthew Lepore
Matthew Lepore |
||
Title: Vice President, Chief Counsel - Corporate Governance,
and Assistant General Counsel
|
||
Dated: December 16, 2009 |
EXHIBIT INDEX
Exhibit No. |
Description |
Exhibit 3.1 | Pfizer Inc. By-laws, as amended on December 14, 2009. |